Aarti Drugs Limited
Aarti Drugs Limited is a Public Non-govt company company incorporated in 1984 and based in Maharashtra, India. Aarti Drugs Limited operates in Other (NIC 37060) with authorized capital of ₹120.00 Cr and paid-up capital of ₹93.20 Cr. For 2017-18, the company reported revenue of ₹1159.66 Cr and profit after tax of ₹73.41 Cr. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
AARTI DRUGS LIMITED is the legal entity of Aarti Drugs.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Aarti Drugs Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Aarti Drugs Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 685811923 | State Bank of India(Bank) | ₹7.81 Cr | 19 Sep 2020 | Open |
| 391503440 | State Bank of India(Bank) | ₹4.80 Cr | 04 Jul 2023 | Satisfied |
| 867842616 | Axis Bank Ltd(Bank) | ₹12.91 Cr | 19 Sep 2022 | Open |
| 647349875 | Kotak Mahindra Bank Ltd(Bank) | ₹7.63 Cr | 04 Jul 2020 | Open |
| 713248246 | Axis Bank Ltd(Bank) | ₹2.39 Cr | 27 Jan 2023 | Open |
| 204131843 | Axis Bank Ltd(Bank) | ₹4.65 Cr | 27 Jan 2021 | Open |
Charge IDs, lenders & amounts for Aarti Drugs Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2017-18 | — |
Detailed Financials
1 FYs| Line item | 2017-18 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹23.65 Cr | +32.5% | +7.7% | +4.2% |
| Profit after Tax | ₹3.56 Cr | +8.8% | +0.3% | +8.4% |
| Net Worth | ₹18.29 Cr | +11.7% | +22.1% | +11.2% |
| Employees | 321 | +23.6% | +10.6% | +10.3% |
Audited financials & ratios for Aarti Drugs Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2017-18 | +6.33% | — | +16.95% | +5.58% | 2.04 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 3,67,85,381 | 88.59% |
| Institutional Investors | 1 | 11,45,225 | 2.76% |
| Public & Others | 8 | 35,93,794 | 8.65% |
Promoter, institutional & public holding for Aarti Drugs Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
44 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.